Zable A C, Favero T G, Abramson J J
Department of Physics, Portland State University, Portland, Oregon 97207, USA.
J Biol Chem. 1997 Mar 14;272(11):7069-77. doi: 10.1074/jbc.272.11.7069.
In this report, we demonstrate the ability of the cellular thiol glutathione to modulate the ryanodine receptor from skeletal muscle sarcoplasmic reticulum. Reduced glutathione (GSH) inhibited Ca2+-stimulated [3H]ryanodine binding to the sarcoplasmic reticulum and inhibited the single-channel gating activity of the reconstituted Ca2+ release channel. The effects of GSH on both the [3H]ryanodine binding and single-channel measurements were dose-dependent, exhibiting an IC50 of approximately 2.4 mM in binding experiments. Scatchard analysis demonstrated that GSH decreased the binding affinity of ryanodine for its receptor (increased Kd) and lowered the maximal binding occupancy (Bmax). In addition, GSH did not modify the Ca2+ dependence of [3H]ryanodine binding. In single-channel experiments, GSH (5-10 mM), added to the cis side of the bilayer lipid membrane, lowered the open probability (Po) of a Ca2+ (50 microM)-stimulated Ca2+ channel without modifying the single-channel conductance. Subsequent perfusion of the cis chamber with an identical buffer, containing 50 microM Ca2+ without GSH, re-established Ca2+-stimulated channel gating. GSH did not inhibit channel activity when added to the trans side of the bilayer lipid membrane. Similar to GSH, the thiol-reducing agents dithiothreitol and beta-mercaptoethanol also inhibited high affinity [3H]ryanodine binding to sarcoplasmic reticulum membranes. In contrast to GSH, glutathione disulfide (GSSG) was a potent stimulator of high affinity [3H]ryanodine binding and it also stimulated the activity of the reconstituted single Ca2+ release channel. These results provide direct evidence that glutathione interacts with reactive thiols associated with the Ca2+ release channel/ryanodine receptor complex, which are located on the cytoplasmic face of the SR, and support previous observations (Liu, G, Abramson, J. J., Zable, A. C., and Pessah, I. N. (1994) Mol. Pharmacol. 45, 189-200) that reactive thiols may be involved in the gating of the Ca2+ release channel.
在本报告中,我们证明了细胞内硫醇谷胱甘肽调节骨骼肌肌浆网中兰尼碱受体的能力。还原型谷胱甘肽(GSH)抑制Ca2 +刺激的[3H]兰尼碱与肌浆网的结合,并抑制重组Ca2 +释放通道的单通道门控活性。GSH对[3H]兰尼碱结合和单通道测量的影响均呈剂量依赖性,在结合实验中IC50约为2.4 mM。Scatchard分析表明,GSH降低了兰尼碱与其受体的结合亲和力(增加Kd)并降低了最大结合占有率(Bmax)。此外,GSH并未改变[3H]兰尼碱结合的Ca2 +依赖性。在单通道实验中,添加到双层脂质膜顺式侧的GSH(5 - 10 mM)降低了Ca2 +(50 microM)刺激的Ca2 +通道的开放概率(Po),而未改变单通道电导。随后用不含GSH的含50 microM Ca2 +的相同缓冲液灌注顺式腔室,重新建立了Ca2 +刺激的通道门控。当添加到双层脂质膜反式侧时,GSH不抑制通道活性。与GSH类似,硫醇还原剂二硫苏糖醇和β-巯基乙醇也抑制[3H]兰尼碱与肌浆网膜的高亲和力结合。与GSH相反,氧化型谷胱甘肽(GSSG)是高亲和力[3H]兰尼碱结合的有效刺激剂,它还刺激重组单Ca2 +释放通道的活性。这些结果提供了直接证据,表明谷胱甘肽与位于肌浆网细胞质面上的与Ca2 +释放通道/兰尼碱受体复合物相关的反应性硫醇相互作用,并支持先前的观察结果(Liu,G,Abramson,J. J.,Zable,A. C.,和Pessah,I. N.((1994)Mol. Pharmacol. 45,189 - 200),即反应性硫醇可能参与Ca2 +释放通道的门控。